XSpray Pharma AB (publ)
F:6XP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
XSpray Pharma AB (publ)
F:6XP
|
SE |
|
A
|
Advanced Micro Devices Inc
MIL:1AMD
|
US |
|
E
|
Equifax Inc
XMUN:EFX
|
US |
|
Zhejiang EV-Tech Co Ltd
SZSE:301607
|
CN |
|
Aloro Mining Corp
F:4LPP
|
CA |
|
Saipem SpA
F:SPE1
|
IT |
|
thyssenkrupp AG
F:TKA
|
DE |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
|
W
|
WSOL PCL
SET:WSOL
|
TH |
|
P
|
Public Service Enterprise Group Inc
DUS:PSE
|
US |
|
Biogaia AB
F:BGL
|
SE |
|
M
|
Metro AG
DUS:B4B
|
DE |
|
El En SpA
F:EE5
|
IT |
|
T
|
Tapestry Inc
XMUN:COY
|
US |
|
E
|
Experian PLC
XMUN:J2B
|
IE |
|
China Merchants Bank Co Ltd
F:M4BB
|
CN |
|
Granite Real Estate Investment Trust
F:4I7
|
CA |
|
J
|
JCDecaux SE
XMUN:DCS
|
FR |
Bankruptcy Probability
XSpray Pharma AB (publ)'s probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
XSpray Pharma AB (publ) Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SE |
|
XSpray Pharma AB (publ)
STO:XSPRAY
|
1.1B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
178.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
108.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
42.6B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
60.1B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
XSpray Pharma AB (publ)'s probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, XSpray Pharma AB (publ) has total debt of 143m SEK. This includes both short-term (0 SEK) and long-term (143m SEK) debt.
You can find a full breakdown on its Balance Sheet.
